LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 11.18 | 84.90 | 6 | 492 | 0.0122 | -0.6483 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 11.18 | 84.90 | 905 | 492 | 1.8381 | 1.5426 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 11.18 | 84.90 | 1049 | 492 | 2.1306 | 1.6950 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.88 | 84.90 | 6 | 531 | 0.0113 | -0.6328 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.88 | 84.90 | 948 | 531 | 1.7853 | 1.4900 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.88 | 84.90 | 2 | 531 | 0.0038 | -0.7576 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.88 | 84.90 | 1078 | 531 | 2.0301 | 1.6140 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.58 | 84.90 | 979 | 663 | 1.4757 | 1.2804 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.58 | 84.90 | 3 | 663 | 0.0045 | -0.6760 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.58 | 84.90 | 1117 | 663 | 1.6837 | 1.3841 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.29 | 84.90 | 10 | 766 | 0.0130 | -0.4901 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.29 | 84.90 | 966 | 766 | 1.2597 | 1.1508 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.29 | 84.90 | 98 | 766 | 0.1278 | 0.0462 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.29 | 84.90 | 1164 | 766 | 1.5179 | 1.2809 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 17.99 | 84.90 | 14 | 898 | 0.0156 | -0.4111 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 17.99 | 84.90 | 985 | 898 | 1.0957 | 1.0544 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 17.99 | 84.90 | 90 | 898 | 0.1001 | 0.0173 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 17.99 | 84.90 | 1204 | 898 | 1.3393 | 1.1792 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 19.69 | 84.90 | 14 | 1239 | 0.0113 | -0.3725 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 19.69 | 84.90 | 1003 | 1239 | 0.8092 | 0.8935 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 19.69 | 84.90 | 271 | 1239 | 0.2187 | 0.3500 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 19.69 | 84.90 | 1230 | 1239 | 0.9924 | 0.9961 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 21.40 | 84.90 | 28 | 1454 | 0.0192 | -0.2371 | MN20160318_Q02 | D16 |